Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Glioblastoma Treatment with Temozolomide and Bevacizumab and Overall Survival in a Rural Tertiary Healthcare Practice
Authors
Keywords
-
Journal
Biomed Research International
Volume 2018, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2019-01-01
DOI
10.1155/2018/6204676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
- (2017) Roger Stupp et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The role of bevacizumab in the treatment of glioblastoma
- (2017) Roberto Jose Diaz et al. JOURNAL OF NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary brain and other central nervous system tumors diagnosed in the United States in 2010–2014
- (2017) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Lomustine and Bevacizumab in Progressive Glioblastoma
- (2017) Wolfgang Wick et al. NEW ENGLAND JOURNAL OF MEDICINE
- Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma-Tailored Gene Panel
- (2016) Angela Zacher et al. BRAIN PATHOLOGY
- Age alone is not a predictor for survival in glioblastoma
- (2016) Lucy Gately et al. JOURNAL OF NEURO-ONCOLOGY
- Tumor treating fields: a novel treatment modality and its use in brain tumors
- (2016) Andreas F. Hottinger et al. NEURO-ONCOLOGY
- Glioblastoma in England: 2007–2011
- (2015) Andrew Brodbelt et al. EUROPEAN JOURNAL OF CANCER
- Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000–2010
- (2015) I-Wen Pan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Epidemiologic and Molecular Prognostic Review of Glioblastoma
- (2014) J. P. Thakkar et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Changing incidence and improved survival of gliomas
- (2014) Vincent K.Y. Ho et al. EUROPEAN JOURNAL OF CANCER
- Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
- (2014) Walter Taal et al. LANCET ONCOLOGY
- Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain
- (2013) F. Graus et al. NEURO-ONCOLOGY
- Time trends in glioblastoma multiforme survival: the role of temozolomide
- (2013) R. Dubrow et al. NEURO-ONCOLOGY
- NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality
- (2012) Roger Stupp et al. EUROPEAN JOURNAL OF CANCER
- Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
- (2012) K. R. Yabroff et al. NEURO-ONCOLOGY
- A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme
- (2012) Pål A. Rønning et al. NEURO-ONCOLOGY
- Adult glioblastoma multiforme survival in the temozolomide era: A population-based analysis of Surveillance, Epidemiology, and End Results registries
- (2011) Amy S. Darefsky et al. CANCER
- Glioblastoma survival in the United States before and during the temozolomide era
- (2011) Derek R. Johnson et al. JOURNAL OF NEURO-ONCOLOGY
- Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas
- (2010) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival
- (2010) Christian Ewelt et al. JOURNAL OF NEURO-ONCOLOGY
- Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004
- (2010) L. Bauchet et al. NEURO-ONCOLOGY
- Patterns of Care and Survival in a Retrospective Analysis of 1059 Patients With Glioblastoma Multiforme Treated Between 2002 and 2007: A Multicenter Study by the Central Nervous System Study Group of Airo (Italian Association of Radiation Oncology)
- (2010) Silvia Scoccianti et al. NEUROSURGERY
- Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
- (2009) Henry S. Friedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
- (2008) Teri N. Kreisl et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma
- (2007) Graziella Filippini et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search